# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 14, "Eye ( Lond ) .", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasJournal> \"Eye ( Lond ) .\"."
1, PublicationYear, 15, 19, "2012", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasPublicationYear> \"2012\"."
2, Title, 102, 275, "Twenty - four hour efficacy with the dorzolamide / timolol - fixed combination compared with the brimonidine / timolol - fixed combination in primary open - angle glaucoma .", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasTitle> \"Twenty - four hour efficacy with the dorzolamide / timolol - fixed combination compared with the brimonidine / timolol - fixed combination in primary open - angle glaucoma .\"."
3, Dorzolamide, 139, 150, "dorzolamide", "", 
5, Dorz/TimFC, 139, 180, "dorzolamide / timolol - fixed combination", "", "<http://ctro/data#Medication_65557> <http://ctro/data#hasDrug> <http://ctro/data#Dorz/TimFC>."
4, Timolol, 153, 160, "timolol", "", 
6, Brimonidine, 199, 210, "brimonidine", "", 
8, Brimo/TimFC, 199, 240, "brimonidine / timolol - fixed combination", "", "<http://ctro/data#Medication_65564> <http://ctro/data#hasDrug> <http://ctro/data#Brimo/TimFC>."
7, Timolol, 213, 220, "timolol", "", 
9, Primary_OpenAngleGlaucoma, 244, 273, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
10, Author, 276, 286, "Konstas AG", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Konstas AG\"."
11, Author, 295, 305, "Quaranta L", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Quaranta L\"."
12, Author, 308, 314, "Yan DB", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Yan DB\"."
13, Author, 317, 331, "Mikropoulos DG", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Mikropoulos DG\"."
14, Author, 334, 340, "Riva I", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Riva I\"."
15, Author, 343, 350, "Gill NK", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Gill NK\"."
16, Author, 353, 361, "Barton K", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Barton K\"."
17, Author, 364, 374, "Haidich AB", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasAuthor> \"Haidich AB\"."
18, Greece, 497, 503, "Greece", "", "<http://ctro/data#Population_65525> <http://ctro/data#hasCountry> <http://ctro/data#Greece>."
19, ObjectiveDescription, 538, 749, "The aim of this study is to compare the 24 - hour efficacy of dorzolamide / timolol - fixed combination ( DTFC ) and brimonidine / timolol - fixed combination ( BTFC ) in primary open - angle glaucoma ( POAG ) .", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasObjectiveDescription> \"The aim of this study is to compare the 24 - hour efficacy of dorzolamide / timolol - fixed combination ( DTFC ) and brimonidine / timolol - fixed combination ( BTFC ) in primary open - angle glaucoma ( POAG ) .\"."
20, Dorzolamide, 600, 611, "dorzolamide", "", 
23, Dorz/TimFC, 600, 641, "dorzolamide / timolol - fixed combination", "", 
21, Timolol, 614, 621, "timolol", "", 
24, Dorz/TimFC, 644, 648, "DTFC", "", 
25, Brimonidine, 655, 666, "brimonidine", "", 
26, Brimo/TimFC, 655, 696, "brimonidine / timolol - fixed combination", "", 
22, Timolol, 669, 676, "timolol", "", 
27, Brimo/TimFC, 699, 703, "BTFC", "", 
28, Primary_OpenAngleGlaucoma, 709, 738, "primary open - angle glaucoma", "", 
29, Primary_OpenAngleGlaucoma, 741, 745, "POAG", "", 
30, NumberPatientsCT, 776, 778, "77", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasNumberPatientsCT> \"77\"."
31, Primary_OpenAngleGlaucoma, 779, 783, "POAG", "", 
32, Prospective, 814, 825, "prospective", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
33, Blind, 828, 845, "observer - masked", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
34, Crossover, 848, 857, "crossover", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasCTDesign> <http://ctro/data#Crossover>."
35, Duration, 883, 892, "2 - month", "", 
36, Timolol, 893, 900, "timolol", "", 
37, IOP, 938, 958, "intraocular pressure", "", 
38, IOP, 961, 964, "IOP", "", 
100, TimePoint, 983, 987, "1000", "", 
101, TimePoint, 990, 994, "1200", "", 
102, TimePoint, 999, 1005, "1400 h", "", 
39, Timolol, 1015, 1022, "timolol", "", 
43, Precondition, 1035, 1092, "Patients showing at least a 20 % IOP reduction on timolol", "", "<http://ctro/data#Population_65525> <http://ctro/data#hasPrecondition> \"Patients showing at least a 20 % IOP reduction on timolol\"."
40, RelativeReduction, 1063, 1065, "20", "", 
41, IOP, 1068, 1071, "IOP", "", 
42, Timolol, 1085, 1092, "timolol", "", 
44, Randomized, 1098, 1108, "randomised", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
45, Duration, 1112, 1120, "3 months", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasCTduration> \"3 months\"."
46, Dorz/TimFC, 1137, 1141, "DTFC", "", 
47, Brimo/TimFC, 1145, 1149, "BTFC", "", 
48, Crossover, 1166, 1178, "crossed over", "", 
49, FinalNumPatientsCT, 1215, 1220, "Sixty", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasFinalNumberPatientsCT> \"Sixty\"."
50, Primary_OpenAngleGlaucoma, 1221, 1225, "POAG", "", 
51, Mean, 1261, 1265, "mean", "", "<http://ctro/data#Mean_65535> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_65533> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_65535>."
89643, EndPointDescription, 1266, 1279, "24 - hour IOP", "", "<http://ctro/data#EndPointDescription_65534> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_65533> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_65534>."
53, Timolol, 1357, 1364, "timolol", "", 
111, Diurnal_IOP, 1375, 1386, "diurnal IOP", "", 
112, PvalueDiff, 1391, 1400, "< 0 . 001", "", 
121, ObservedResult, 1405, 1534, "When the two fixed combinations were compared directly , DTFC demonstrated a lower mean 24 - hour IOP level as compared with BTFC", "", "<http://ctro/data#Outcome_65583> <http://ctro/data#hasObservedResult> \"When the two fixed combinations were compared directly , DTFC demonstrated a lower mean 24 - hour IOP level as compared with BTFC\". <http://ctro/data#Outcome_65619> <http://ctro/data#hasObservedResult> \"When the two fixed combinations were compared directly , DTFC demonstrated a lower mean 24 - hour IOP level as compared with BTFC\"."
56, Dorz/TimFC, 1462, 1466, "DTFC", "", 
57, Mean, 1488, 1492, "mean", "", 
89644, EndPointDescription, 1493, 1506, "24 - hour IOP", "", 
59, Brimo/TimFC, 1530, 1534, "BTFC", "", 
60, Mean, 1537, 1541, "mean", "", 
134, DiffGroupAbsValue, 1555, 1562, "- 0 . 7", "", "<http://ctro/data#DiffBetweenGroups_65610> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 7\"."
118, mmHg, 1563, 1568, "mm Hg", "", "<http://ctro/data#Endpoint_65533> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
119, ConfIntervalDiff, 1571, 1624, "95 % confidence interval ( CI ) : ( - 1 . 0 , - 0 . 3", "", "<http://ctro/data#DiffBetweenGroups_65610> <http://ctro/data#hasConfIntervalDiff> \"95 % confidence interval ( CI ) : ( - 1 . 0 , - 0 . 3\"."
120, PvalueDiff, 1629, 1640, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_65610> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
122, Dorz/TimFC, 1677, 1681, "DTFC", "", "<http://ctro/data#Outcome_65583> <http://ctro/data#hasObservedResult> \"When the two fixed combinations were compared directly , DTFC demonstrated a lower mean 24 - hour IOP level as compared with BTFC\". <http://ctro/data#Outcome_65619> <http://ctro/data#hasObservedResult> \"When the two fixed combinations were compared directly , DTFC demonstrated a lower mean 24 - hour IOP level as compared with BTFC\"."
123, IOP, 1704, 1707, "IOP", "", "<http://ctro/data#IOP_65701> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_65700> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_65701>."
124, Brimo/TimFC, 1718, 1722, "BTFC", "", 
125, TimePoint, 1728, 1734, "1800 h", "", "<http://ctro/data#Outcome_65646> <http://ctro/data#hasTimePoint> \"1800 h\". <http://ctro/data#Outcome_102291> <http://ctro/data#hasTimePoint> \"1800 h\"."
133, DiffGroupAbsValue, 1737, 1744, "- 1 . 0", "", "<http://ctro/data#DiffBetweenGroups_65705> <http://ctro/data#hasDiffGroupAbsValue> \"- 1 . 0\"."
127, mmHg, 1745, 1750, "mm Hg", "", "<http://ctro/data#Endpoint_65700> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
129, ConfIntervalDiff, 1753, 1780, "95 % CI ( - 1 . 6 , - 0 . 5", "", "<http://ctro/data#DiffBetweenGroups_65705> <http://ctro/data#hasConfIntervalDiff> \"95 % CI ( - 1 . 6 , - 0 . 5\"."
130, PvalueDiff, 1785, 1796, "P = 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_65705> <http://ctro/data#hasPvalueDiff> \"P = 0 . 001\"."
126, TimePoint, 1806, 1810, "0200", "", "<http://ctro/data#Outcome_65673> <http://ctro/data#hasTimePoint> \"0200\". <http://ctro/data#Outcome_102318> <http://ctro/data#hasTimePoint> \"0200\"."
135, DiffGroupAbsValue, 1813, 1820, "- 0 . 9", "", "<http://ctro/data#DiffBetweenGroups_65714> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 9\"."
128, mmHg, 1821, 1826, "mm Hg", "", 
132, ConfIntervalDiff, 1829, 1858, "95 % CI : ( - 1 . 4 , - 0 . 5", "", "<http://ctro/data#DiffBetweenGroups_65714> <http://ctro/data#hasConfIntervalDiff> \"95 % CI : ( - 1 . 4 , - 0 . 5\"."
131, PvalueDiff, 1863, 1874, "P = 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_65714> <http://ctro/data#hasPvalueDiff> \"P = 0 . 001\"."
141, ConclusionComment, 1954, 2026, "Both the fixed combinations significantly reduce 24 - hour IOP in POAG .", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasConclusionComment> \"Both the fixed combinations significantly reduce 24 - hour IOP in POAG .\"."
137, IOP, 2013, 2016, "IOP", "", 
138, Primary_OpenAngleGlaucoma, 2020, 2024, "POAG", "", 
139, Dorz/TimFC, 2027, 2031, "DTFC", "", 
141, ConclusionComment, 2027, 2082, "DTFC provided significantly better 24 - hour efficacy .", "", "<http://ctro/data#ClinicalTrial_65504> <http://ctro/data#hasConclusionComment> \"DTFC provided significantly better 24 - hour efficacy .\"."
140, PMID, 2144, 2152, "21960068", "", "<http://ctro/data#Publication_65490> <http://ctro/data#hasPMID> \"21960068\"."
